Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: A cardiovascular magnetic resonance imaging study

International Journal of Cardiovascular Imaging

Volumn 29, Issue 2, 2013, Pages 395-404

  Khan, Razi ^a   Massel, David ^a   Stirrat, John ^a   Scholl, David ^a   Wisenberg, Gerald ^a   Thompson, Terry ^a   Drangova, Maria ^a   White, James A ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

Dilated Cardiomyopathy; Hypertrophic Cardiomyopathy; Late Gadolinium Enhancement magnetic resonance imaging; Myocardial fibrosis; Quality of life

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINNESOTA LIVING WITH HEART FAILURE; NONISCHEMIC CARDIOMYOPATHY; QUALITY OF LIFE; SHORT FORM 12;

ADULT; AGED; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; FEMALE; FIBROSIS; GADOLINIUM DTPA; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84874302613     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-012-0107-4     Document Type: Article

References (39)

1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (Young) adults. Circulation 92:785-789
2. Dec GW, Fuster V (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 331:1564-1575 (Pubitemid 24366905)
3. White JA, Patel MR (2007) The role of cardiovascular MRI in heart failure and the cardiomyopathies. Cardiol Clin 25:71-95 (Pubitemid 46661974)
4. Bruder O, Wagner A, Jensen CJ et al (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56:875-887
5. Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977-1985 (Pubitemid 44738448)
6. O'Hanlon R, Grasso A, Roughton M et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867-874
7. Rubinshtein R, Glockner JF, Ommen SR et al (2010) Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 3:51-58
8. Wu KC, Weiss RG, Thiemann DR et al (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51:2414-2421 (Pubitemid 351826874)
9. Kato N, Kinugawa K, Seki S et al (2011) Quality of life as an independent predictor for cardiac events and death in patients with heart failure. Circ J 75:1661-1669
10. Iqbal J, Francis L, Reid J, Murray S, Denvir M (2010) Quality of life in patients with chronic heart failure and their carers: a 3-year follow-up study assessing hospitalization and mortality. Eur J Heart Fail 12:1002-1008
11. Carson P, Tam SW, Ghali JK et al (2009) Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial. J Card Fail 15:835-842
12. Steptoe A, Mohabir A, Mahon N, McKenna W (2000) Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy. Heart 83:645-650 (Pubitemid 30345964)
13. Waagstein F, Hjalmarson A, Swedberg K et al (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342:1441-1446 (Pubitemid 24000287)
14. Konstam V, Salem D, Pouleur H et al (1996) Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. Am J Cardiol 78:890-895 (Pubitemid 126658649)
15. Cox S, O'Donoghue AC, McKenna WJ, Steptoe A (1997) Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. Heart 78:182-187 (Pubitemid 27404956)
16. Adabag AS, Maron BJ, Appelbaum E et al (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51:1369-1374 (Pubitemid 351443083)
17. Mitani H, Hashimoto H, Isshiki T et al (2003) Health-related quality of life of Japanese patients with chronic heart failure: assessment using the medical outcome study short form 36. Circ J 67:215-220 (Pubitemid 36362495)
18. Hobbs FR, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK (2002) Impact of heart failure and left ventricular systolic dysfunction on quality of life. A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 23:1867-1876 (Pubitemid 35398056)
19. Jellis C, Wright J, Kennedy D et al (2011) Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circ Cardiovasc Imaging 4:693-702
20. Romero-Puche A, Marín F, González-Carrillo J et al (2008) Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathy. Rev Esp Cardiol 61:853-860
21. Roldán V, Marín F, Gimeno JR, Ruiz-Espejo F et al (2008) Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. Am Heart J 156:85-91 (Pubitemid 351862294)
22. Karaahmet T, Tigen K, Dundar C et al (2010) The effect of cardiac fibrosis on left ventricular remodeling, diastolic function, and N-terminal pro-B-type natriuretic peptide levels in patients with nonischemic dilated cardiomyopathy. Echocardiography 27:954-960
23. Tigen K, Karaahmet T, Kirma C et al (2010) Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy. J Am Soc Echocardiography 23:416-422
24. Maron BJ, McKenna WJ, Danielson GK et al (2003) Task force on clinical expert consensus documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:1687-1713 (Pubitemid 37383745)
25. Kim RJSD, Judd RM (2003) How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 5:505-514 (Pubitemid 36859434)
26. Kim RJ, Fieno DS, Parrish TB et al (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992-2002 (Pubitemid 29529292)
27. Gao P, Gula L, Yee R et al (2012) Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardioverter-defibrillator: evaluation of multiple scar quantification measure for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging 5:448-456
28. Rector T, Kubo S, Cohn J (1987) Patient's self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, the Minnesota living with heart failure questionnaire. Heart Failure 3:198-209
29. Ware JE Jr, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220-233 (Pubitemid 126433231)
30. Hundley WG, Bluemke D, Bogaert JG et al (2009) Society for cardiovascular magnetic resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson 11:5
31. Edelmann F, Stahrenberg R, Polzin F et al (2011) Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters: quality of life in diastolic dysfunction. Am Heart J 16:797-804
32. Huff CM, Turer AT, Wang A (2012) Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy. Qual Life Res. doi: 10.1007/s11136-012-0182-y
33. Myers J, Zaheer N, Quaglietti S, Madhavan R, Froelicher V, Heidenreich P (2006) Association of functional and health status measures in heart failure. J Card Fail 12:439-445 (Pubitemid 46106981)
34. Hoth KF, Nash J, Poppas A, Ellison KE, Paul RH, Cohen RA (2008) Effects of cardiac resynchronization therapy on health-related quality of life in older adults with heart failure. Clin Interv Aging 3:553-560
35. Abdelhadi R, Adelstein E, Voigt A, Gorcsan J, Saba S (2008) Measures of left ventricular dyssynchrony and the correlation to clinical and echocardiographic response after cardiac resynchronization therapy. Am J Cardiol 102:598-601
36. Olivotto I, Maron BJ, Appelbaum E et al (2010) Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol 106:261-267
37. Masci PG, Barison A, Aquaro GD et al (2012) Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy. Int J Cardiol 157:43-47
38. Flett AS, Hasleton J, Cook C et al (2011) Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 4:150-156
39. Marsan NA, Bax JJ (2010) Cardiomyopathies: myocardial fibrosis assessed by CMR to predict events in HCM. Nat Rev Cardiol 7:604-606